As one of only three glucagon-like peptide 1 (GLP-1) receptor agonists approved for weight loss in people with obesity or who are overweight, Wegovy (semaglutide) is on its way to becoming as popular as its Type 2 diabetes-approved counterpart, Ozempic
Your cart is empty :( Your cart Loading
The Overlap Risk: Why Concurrent Use Is Not Recommended The Pharmaceutical Journal (Royal Pharmaceutical Society, December 2025) states that concurrent administration of tirzepatide and semaglutide "could heighten side effects" due to their "overlapping incretin activity." When both drugs are active simultaneously, the GLP-1 receptor faces amplified agonist load
Added Mulberry Extract and Vitamin E offer antioxidant protection and skin-soothing benefits, making this the perfect everyday cleanser for a soft, radiant, and even-toned complexion
She has 15 years of experience in the beauty industry and 13 years as a registered nurse
If you notice new or worsening skin symptoms after starting Rybelsus, it is important to document the timing, location, and nature of these changes to discuss with your healthcare provider
